This meeting took place in Barcelona, Spain, from 2–3rd October 2019. The Lymphoma Coalition (LC) represents lymphoma patient advocacy groups from all over the world and strives for equity in lymphoma treatment outcomes across borders. It has 82 members across 52 countries. All members are volunteers offering informational support to newly diagnosed patients, and promote communication amongst various stakeholders involved in lymphoma care in their country. The author represented the “Hodgkin en non-Hodgkin VZW” from Belgium at this international meeting.

(BELG J HEMATOL 2019;10(7):290–6)